QA: IGM Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001496323_2023_IGM_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001496323, IGM Biosciences Inc.

  xvar xval
0 AssetsCurrent 438,421,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 33,484,000
3 remainder_Assets 41,594,000
4 LiabilitiesCurrent 44,685,000
5 LiabilitiesNoncurrent 35,356,000
6 remainder_Liabilities 146,195,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 49,736,000
9 ResearchAndDevelopmentExpense 179,289,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 7,923,000
13 remainder_ComprehensiveNetIncome -635,000
  yvar yval
0 Assets 513,499,000
1 Liabilities 226,236,000
2 Expenses 229,025,000
3 Revenues 0
4 StockholdersEquity 287,263,000
5 NetIncome -221,102,000
6 ComprehensiveNetIncome -221,419,500
7 BaseVar 488,659,000
8 EconomicCapitalRatio 0.737

Edgar->Model Mapping

Feature Distribution

Change over Time